Devises / LLY
LLY: Eli Lilly and Company
726.80
USD
16.13
(2.17%)
Le taux de change de LLY a changé de -2.17% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 722.57 et à un maximum de 744.18.
Suivez la dynamique Eli Lilly and Company. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LLY Nouvelles
- Top 50 High-Quality Dividend Stocks For September 2025
- Dividend Champion, Contender, And Challenger Highlights: Week Of September 7
- Novo Nordisk: Keep It Low So I Can Keep Accumulating (Rating Upgrade) (NYSE:NVO)
- Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data - Skye Bioscience (NASDAQ:SKYE)
- Novo Nordisk Vs Eli Lilly: Novo A Clear Winner (NYSE:NVO)
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories! - TipRanks.com
- Eli Lilly and Company (LLY) Presents at 2025 Wells Fargo Healthcare Conference
- Eli Lilly at Wells Fargo Conference: Strategic Growth Insights
- Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks (NYSE:PFE)
- Is Eli Lilly Stock a Buy After Gaining 5% in 1 Day?
- Weight loss has become the hottest new Chinese consumer craze
- 2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts
- Tracking Chase Coleman's Tiger Global Portfolio—Q2 2025 Update
- Bicara Therapeutics: Promising, But Only For The Patient (NASDAQ:BCAX)
- Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity?
- Lilly-Merck Combo Drug For Lung Cancer Receives FDA Breakthrough Status - Eli Lilly (NYSE:LLY)
- Why obesity stocks are struggling in 2025?
- Polar Capital Global Healthcare Trust reveals top holdings
- Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar'
- FDA grants breakthrough therapy designation to Lilly’s lung cancer drug
- Hims and Hers stock rating maintained at Underperform by BofA Securities
- Where Will Eli Lilly Be in 3 Years?
- Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris
- Eli Lilly's Stock Fall Is An Opportunity (NYSE:LLY)
Range quotidien
722.57
744.18
Range Annuel
644.51
937.00
- Clôture Précédente
- 742.93
- Ouverture
- 744.18
- Bid
- 726.80
- Ask
- 727.10
- Plus Bas
- 722.57
- Plus Haut
- 744.18
- Volume
- 5.620 K
- Changement quotidien
- -2.17%
- Changement Mensuel
- -0.16%
- Changement à 6 Mois
- -11.26%
- Changement Annuel
- -18.23%
07 septembre, dimanche